Глобальна гаряча лінія для українських пацієнтів-біженців, які беруть участь у клінічному випробуванні Amgen. Натисніть тут для отримання додаткової інформації.
Глобальная горячая линия для украинских пациентов-беженцев, участвующих в клиническом исследовании Amgen. Для получения дополнительной информации нажмите здесь.
Patients 09.23.2022
Since its establishment in 2012, Amgen China has worked with its commercial partners to bring six innovative medicines to Chinese patients, with more on the way.
Leadership 09.16.2022
Responsibility 09.15.2022
Patients 09.13.2022
Science & Innovation 09.09.2022
The largest and broadest global KRASG12C inhibitor development program is progressing to help more patients.
Responsibility 09.08.2022
Dora Menchaca, an Amgen employee, died on 9/11 leaving friends and family grieving. But a donation in her memory to UCLA by Amgen continues to help those fighting cancer.
PRESS RELEASE
Amgen is a pioneer in the science of using living cells to make biologic medicines.
Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options.
Making a positive difference in the world is at the heart of what we do at Amgen—and it goes beyond making vital medicines.
Amgen is a pioneer in the science of using living cells to making biologic medicines, leading and guiding the biotech industry.
Encounter opportunities both new and undiscovered, as we embrace leading-edge technologies, invest in our talents, and maximize our potential.
